Log in
Donate

Clinical Trial: SWOG S1800E

SWOG S1800E

Status: New, Open

NCT#06616584

A Randomized Phase II/III Study of Docetaxel and Ramucirumab with or Without Cemiplimab (REGN2810) for Participants Previously Treated with Platinum-Based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study)

CLASS Site Initiation Training completion is required prior to patient registration.  See S1800E Protocol, Section 15.1 for link. 

See Screening Protocol LUNGMAP

View All Clinical Trials
The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved